IR-Med Inc. (IRME)
OTCMKTS · Delayed Price · Currency is USD
0.1200
+0.0200 (20.00%)
At close: May 14, 2025

IR-Med Statistics

Total Valuation

IR-Med has a market cap or net worth of 8.64 million. The enterprise value is 8.67 million.

Market Cap 8.64M
Enterprise Value 8.67M

Important Dates

The last earnings date was Monday, May 12, 2025.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

IR-Med has 72.02 million shares outstanding. The number of shares has increased by 6.93% in one year.

Current Share Class 72.02M
Shares Outstanding 72.02M
Shares Change (YoY) +6.93%
Shares Change (QoQ) +8.90%
Owned by Insiders (%) 61.08%
Owned by Institutions (%) n/a
Float 24.18M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio -17.53
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -4.30
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.13

Current Ratio 0.13
Quick Ratio 0.13
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -512.00

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -273.12%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 311.56%
Revenue Per Employee n/a
Profits Per Employee -503,750
Employee Count 4
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.89% in the last 52 weeks. The beta is 1.44, so IR-Med's price volatility has been higher than the market average.

Beta (5Y) 1.44
52-Week Price Change -88.89%
50-Day Moving Average 0.43
200-Day Moving Average 0.75
Relative Strength Index (RSI) 38.28
Average Volume (20 Days) 37,339

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.54M
Pretax Income -2.02M
Net Income -2.02M
EBITDA -1.52M
EBIT -1.54M
Earnings Per Share (EPS) -0.03
Full Income Statement

Balance Sheet

The company has 51,000 in cash and 158,000 in debt, giving a net cash position of -107,000 or -0.00 per share.

Cash & Cash Equivalents 51,000
Total Debt 158,000
Net Cash -107,000
Net Cash Per Share -0.00
Equity (Book Value) -493,000
Book Value Per Share -0.01
Working Capital -536,000
Full Balance Sheet

Cash Flow

Operating Cash Flow -1.14M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IR-Med does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.93%
Shareholder Yield -6.93%
Earnings Yield -23.32%
FCF Yield n/a

Stock Splits

The last stock split was on February 26, 2020. It was a reverse split with a ratio of 0.001.

Last Split Date Feb 26, 2020
Split Type Reverse
Split Ratio 0.001

Scores

Altman Z-Score n/a
Piotroski F-Score n/a